TrialCancer chemotherapy and pharmacology2022

Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies.

Jinhui Xue et al.PubMed ↗Publisher ↗

No numbers read from the abstract.